Matignon Technologies
VC Fund
Paris, France
Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000and the Fund has a lifespan of six years.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Matignon Technologies invests in
Stages Matignon Technologies invests in
Countries Matignon Technologies invests in
Investment Focus
Industry
- Medical 2 (67%)
- Biotechnology 2 (67%)
- Medical Device 2 (67%)
- Wellness 1 (33%)
- Health Care 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Funding Round 1 (33%)
Country
- United States 2 (67%)
- France 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Arterial Remodeling Technologies SA engages in developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. The company was founded in 2002 and is based in Noisy le Roi, France. | $8.5M / Sep 21, 2010 | ||
| Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine. The company's patented product is DiscCell, an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc.Gentis wasfounded on 2000 and is headquartered in Wayne, Pennsylvania. | $10M / Series A / Jun 21, 2007 | ||
| Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology. | $10M / Series B / Jul 30, 2004 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Matignon Technologies invest in?
Matignon Technologies invests primarily in Medical, Biotechnology and Medical Device startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Matignon Technologies last invest?
The most recent investment recorded for Matignon Technologies closed in Sep 2010. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
